https://m2squareconsultancy.com/reports/biologics-contract-manufacturing-market

Top 10 Companies Leading Culture Medium Market Growth According to a newly published market research report by 24LifeSciences, global culture medium market was valued at USD 2.68 billion in 2024 and is projected to reach USD 5.24 billion by 2031, growing at a compound annual growth rate (CAGR) of 10.3% during the forecast period. Culture media are essential substrates used to support the growth of cells and microorganisms in a wide range of applications, including scientific research, diagnostics, and biopharmaceutical production. These media consist of nutrient-rich formulations prepared in buffered solutions and are available in both liquid and dry powder forms. They play a critical role in enabling cell culture processes, which are foundational to vaccine development, biologics manufacturing, and advanced therapeutic research. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3622/culture-medium-market

Chromatographic Separation Resin Market to Reach USD 7.86 Billion by 2032 | 9.7% CAGR Growth Amid Biologics Boom According to a recent industry report, the market size was valued at USD 3.75 billion in 2024. With a projected compound annual growth rate (CAGR) of 9.7%, the market is expected to climb from USD 4.12 billion in 2025 to an impressive USD 7.86 billion by 2032. ➤ Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/193818/chromatographic-separation-resin-market

Large Volume Wearable Injectors Market Growth Analysis: Opportunities & Forecasts According to a newly published market research report by 24LifeSciences, global large volume wearable injectors market is valued at USD 1.83 billion in 2026 and is projected to reach USD 15.17 billion by 2034, growing at a compound annual growth rate (CAGR) of 36.2% during the forecast period. Large volume wearable injectors (LVPIs), sometimes referred to as bolus injectors or on-body delivery systems, are advanced medical devices engineered to administer subcutaneous injections of high-volume drug formulations, typically exceeding 2 ml. These systems are designed to be discreet, portable, and patient-friendly, allowing for the self-administration of complex biologics and other therapies over extended periods, from several minutes to hours, outside of a clinical environment. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7264/large-volume-wearable-injectors-market

CPHI Worldwide 2026 Exhibition Stand Builder in Milan The CPHI Milan 2026 is one of the world’s most influential pharmaceutical exhibitions. It gathers the entire global pharma supply chain under one roof. The show displays everything, such as raw materials, APIs, finished dosage, packaging, biologics, and digital pharma solutions. The CPHI Worldwide Milan will take place from 6 to 8 October 2026 at Fiera Milano, Italy, welcoming professionals from across the pharmaceutical value chain.With over 62,000 attendees, 2,400+ exhibitors, and participants from 166+ countries, CPHI Worldwide 2026 Milan is not just another trade show. It’s a competitive environment where brands are noticed in seconds. Thus, having a unique exhibition stand design for CPHI 2025 is important. As an experienced exhibition stand builder for CPHI 2026, Connect Displays helps pharma, biotech, CDMO, and packaging brands stand out clearly. https://expoconnectdisplays.com/upcoming-trade-show/cphi-worldwide/

Adroitix delivers specialized Pharma engineering services for biotech and injectables, offering end-to-end facility design, cleanroom engineering, aseptic process integration, and regulatory compliance support. Our expertise enables the creation of world-class, cGMP-compliant sterile and biologics manufacturing environments—ensuring product safety, operational efficiency, and seamless approvals from global agencies like USFDA, EU-GMP, and WHO. Visit: https://adroitix.com/our-expertise/pharmaceuticals